Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1771-1780 of 2919 for cancer

Edit search filters
  1. A Study Of BBI608 Plus Weekly Paclitaxel To Treat Gastric And Gastro-Esophageal Junction Cancer

    Scottsdale/Phoenix, AZ

  2. Fat Emulsion In Preventing Hypersensitivity Reactions In Patients With Cancer Receiving Carboplatin Or Oxaliplatin

    Rochester, MN

  3. A Study Of Proton Radiation Divided Into Fewer Doses For Low Risk Prostate Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. A Phase Ib Study Of Cobimetinib Administered In Combination With Niraparib, With Or Without Atezolizumab, To Patients With Advanced Platinum-Sensitive Ovarian Cancer

    Jacksonville, FL

  5. A Study Of 9-ING-41 In Patients With Advanced Cancers

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. Evaluate Risk/Benefit Of Nab Paclitaxel In Combination With Gemcitabine And Carboplatin Compared To Gemcitabine And Carboplatin In Triple Negative Metastatic Breast Cancer (Or Metastatic Triple Negative Breast Cancer)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study Of Sonodynamic Therapy Using SONALA-001 And Exablate 4000 Type 2.0 In Subjects With Recurrent GBM

    Rochester, MN

  8. Study Of Adjuvant Regorafenib Vs Placebo In Patients With Node Positive Esophageal Cancer Who Completed Pre-operative Therapy

    Rochester, MN

  9. Controlled Low Calorie Diet In Reducing Side Effects And Increasing Response To Chemotherapy In Patients With Breast Or Prostate Cancer

    Rochester, MN

  10. A Study To Evaluate AVB-S6-500 With Paclitaxel Vs Paclitaxel In Patients With Platinum-resistant Recurrent Ovarian Cancer

    Rochester, MN

.

Mayo Clinic Footer